Each forward-looking statement is subject to risks and uncertainties that could cause actual results and events to differ materially from those projected in that statement. A more complete description ...
5d
Kyntra Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Phase 2 monotherapy trial of FG-3246, a potential first-in-class antibody drug conjugate (ADC) targeting CD46, in metastatic castration-resistant prostate cancer (mCRPC) is actively enrolling and ...
About FactSet Research Systems Inc. FactSet Research Systems Inc. (the "Company" or "FactSet") is a global financial digital platform and enterprise solutions provider with open and flexible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results